SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Company Response from Fit For Business International Inc (CIK 0001312623) — May 4, 2005

Fit For Business International Inc (CIK 0001312623)
Date: May 4, 2005 · CIK: 0001312623 · Accession: 0001312623-05-000002

AI Filing Summary & Sentiment

File numbers found in text: 333-123176

Referenced dates: June 7, 1999

Date
May 4, 2005
Author
Not clearly detected
Form
CORRESP
Company
Fit For Business International Inc (CIK 0001312623)

Letter

May 4, 2005 Jay Ingram, Esq. United States Securities and Exchange Commission 450 Fifth Street, N.W. Washington, D.C. 20549

RE: Fit For Business International, Inc. ("FFB") Registration Statement on Form SB-2 Filed: March 7, 2005 File No. 333-123176

Dear Mr. Ingram:

We have reviewed your April 6, 2005 letter and have the following responses:

General -------

1. We note that your registration statement registers the resale of up to 2,870,000 shares of common stock by selling shareholders. We also note that there is currently no market for your common shares. Given this, please revise your prospectus cover page, the risk factors section, and the plan of distribution section to provide that selling security holders will sell at a stated, fixed price until the securities are quoted on the OTC Bulletin Board and, thereafter, the selling security holders may sell at prevailing market prices or privately negotiated prices. See Item 16 of Schedule A to the Securities Act of 1933. Recalculate your registration fee, if necessary, based upon this offering price.

ANSWER: In Amendment No. 1 to Form SB-2, we have made the requested changes on the prospectus cover page and plan of distribution, added a risk factor and plan of distribution. Based on our revisions, there was no need to recalculate the registration fee.

2. We note the registration of 2,000,000 shares of common stock to be issued "in connection with the conversion of options issued to Fort Street Equity." You are reminded that it is the position of the staff that the securities underlying securities that were sold privately must also be converted privately pursuant to an exemption from registration. They are part of the same transaction. Only the resales of the underlying securities may be registered by this registration statement and the exercise or conversion transaction between the selling shareholders and the company remains private, subject to the limitations of available exemptions. Please revise disclosure throughout the prospectus accordingly.

ANSWER: In Amendment No. 1 to Form SB-2, we have made the requested changes to indicate that FFB is registering the resale of the shares underlying the conversion of options.

<PAGE>

3. Revise your disclosure referencing your intent to have the company's securities listed on the OTC Bulletin Board to clarify that there is no assurance that such securities will be listed for trading on the OTC Bulletin Board.

ANSWER: In Amendment No. 1 to Form SB-2, we have revised our disclosure to clarify that there is no assurance that FFB's securities will be quoted on the OTC Bulletin Board.

4. Please provide the disclosure required by Item 510 of Regulation S-B, Disclosure of Commission Position on Indemnification for Securities Act Liabilities.

ANSWER: The original filed SB-2 registration statement contained the information required by this question in Item 24 (Commission's position on indemnification) and Item 28 (B) (undertaking in the first sentence of Item 512(e)).

Prospectus Cover Page ---------------------

5. Please limit your disclosure on the cover page to that information required by Item 501 of Regulation S-B. For example, consider removing the reference to the state of incorporation, the par value of the common stock, and the information contained in the third paragraph. Since the information in the third paragraph will be addressed later in the prospectus, you do not need to include this disclosure on the cover page. Also, please remove all parenthetically defined terms such as "the Company," "the Offering," and "the Initial Offering Period." The use of these defined terms inhibits the readability of the cover page.

ANSWER: In Amendment No. 1 to Form SB-2, we have made revisions to limit our disclosure on the cover page.

6. Please limit the outside front cover of the prospectus to one page. Refer to Item 501(a) of Regulation S-B.

ANSWER: In Amendment No. 1 to Form SB-2, we have limited the front cover of the prospectus to one page.

7. Please disclose the type of offering by the company. For instance, is this a self underwritten no minimum, minimum-maximum or all-or-none? Also, please disclose whether there are any minimum purchase requirements and whether or not there are any arrangements to place the funds in an escrow, trust or similar account, as required by Item 501(a)(9)(iii) of Regulation S-B.

ANSWER: In Amendment No. 1 to Form SB-2, we have included language stating that the offering is a self underwritten, no minimum offering and that there is no requirement to place any proceeds in escrow.

8. Clarify what you mean when you disclose that the company's shares "are not listed on any recognized exchange."

<PAGE>

ANSWER: In Amendment No. 1 to Form SB-2, we have deleted the word "recognized" and added the word "stock."

9. Revise your cross-reference to the risk factors section by including a page number where the risk factors section appears in the prospectus. See Item 501(a)(5) of Regulation S-B.

ANSWER: In Amendment No. 1 to Form SB-2, we have added a cross reference page number.

10. Please provide the disclosure required by Item 501(a)(9)(iv) of Regulation S-B.

ANSWER: In Amendment No. 1 to Form SB-2, we have provided the required disclosure.

11. We do not understand the following disclosure: "This registration statement will be amended and completed from time to time, as necessary." Supplementally advise.

ANSWER: In Amendment No. 1 to Form SB-2, this statement has been deleted.

Inside Front and Outside Back Cover Page ----------------------------------------

12. Please provide the dealer prospectus delivery obligation as required by Item 502(b) of Regulation S-B.

ANSWER: In Amendment No. 1 to Form SB-2, we have provided the dealer prospectus delivery obligation.

Prospectus Summary ------------------

13. Please add summary financial data.

ANSWER: In Amendment No. 1 to Form SB-2, we have added a summary financial data table.

14. Please add disclosure addressing the company's going concern qualification.

ANSWER: In Amendment No. 1 to Form SB-2, we have added disclosure regarding the company's going concern qualification.

About Us --------

15. Clarify your disclosure in this section regarding the corporate history of the registrant. For example, when addressing the acquisition of all of the issued and outstanding shares of Fit For Business (Australia) Pty Limited, consider disclosing that Mark A. Poulsen and Mark Poulsen & Associates Pty. Ltd were, as it

<PAGE>

currently appears, 100% owners of Fit For Business (Australia). Also, in the second paragraph, explain your use of the term "wholly owned subsidiary" as it relates to the reverse merger. Revise similar disclosure in the "Business" section. Are your operations conducted through your subsidiary? If so, please make this explicit.

ANSWER: In Amendment No. 1 to Form SB-2, we have made the requested disclosures.

Securities Offered By Us ------------------------

16. Please add disclosure addressing the nature of the secondary offerings.

ANSWER: In Amendment No. 1 to Form SB-2, we have added the requested disclosure.

17. Please explain the statement on page 8 that "you will be purchasing our shares from us and not our selling security holders." This registration statement includes the resale of the selling security holders.

ANSWER: This statement has been deleted. This statement was included to disclose that purchasers of the 1,500,000 shares offered were receiving the shares from us and not from the shares being offered by the selling security holders.

Risk Factors ------------

18. Please add an introductory paragraph that states all "material" risks are disclosed in this section.

ANSWER: In Amendment No. 1 to Form SB-2, we have added such disclosure.

19. Revise your risk factor subheadings to ensure that your subheadings clearly reflect the material risk enclosed in the narrative. For example, the subheading for risk factor 4 merely states the fact your business is subject to extensive government regulation. Please revise your subheadings so that they adequately describe the specific risk that results from the stated fact. To assist you in this regard, we refer you to " Plain English Handbook-How to Create Clear SEC Disclosure Documents," issued by the Office of Investor Education and Assistance, which is available on our website at www.sec.gov , and the updated version of Staff Legal Bulletin No. 7, dated June 7, 1999.

ANSWER: In Amendment No.1 to Form SB-2, we have revised the risk factor headings.

20. In the first risk factor, disclose the circumstances under which the stated risk could materialize. For example, describe the circumstances under which the company will lose these key personnel. Also, explain why these persons are "essential" to your operations and growth. What are the roles and responsibilities of these individuals?

ANSWER: In Amendment No.1 to Form SB-2, we have revised the first risk factor accordingly.

<PAGE>

21. Please avoid generic conclusion you reach in many of your risk factors that the risk could negatively impact or have an adverse effect on your business or your business could suffer negative consequences. Instead, replace this language with specific disclosure of how your business and operations would be affected.

ANSWER: In Amendment No.1 to Form SB-2, we have revised certain risk factors accordingly.

22. Consider combining the fourth and fifth risk factor, as they both focus on the governmental regulations regarding your business and Herbalife.

ANSWER: In Amendment No.1 to Form SB-2, we have combined the fourth and fifth risk factor.

23. Please remove risk factors six and nine, as they are generic risks.

ANSWER: In Amendment No.1 to Form SB-2, we have removed risk factors six and nine.

24. Please add risk factors discussing dilution to investors in this offering, risks associated with doing business in a foreign country, currency fluctuations, and the going concern raised by the independent auditors.

ANSWER: In Amendment No.1 to Form SB-2, we have added risk factors as follows: dilution to investors in this offering, risks associated with doing business in a foreign country, currency fluctuations, and the going concern raised by the independent auditors.

Use of Proceeds ---------------

25. To the extent practicable, please provide more specific disclosure regarding the allocation of the use of proceeds. For each enumerated use, add disclosure discussing the items that comprise each use. We specifically refer you to the Multi Media Training Programs; Marketing, Promotion Literature and Brand Campaign Costs; International Market Development. Currently, the disclosure is vague. Also, provide more specificity concerning the amount allocated to working capital.

ANSWER: In Amendment No.1 to Form SB-2, we have added specific disclosure regarding the allocation of the use of proceeds.

26. We note your statement that the "[t]he net proceeds may be reallocated among the categories set forth above or otherwise depending upon the state of our business operations and other factors, many of which are beyond our control." Be advised that you may change the use of proceeds provided such reservation is due to certain contingencies that are specifically discussed and the alternatives to such use are indicated. Refer to Instruction 7 to Item 504 of Regulation S-K for guidance. Please revise your disclosure accordingly.

<PAGE>

ANSWER: In Amendment No.1 to Form SB-2, we have deleted this sentence.

27. Please discuss the allocation of proceeds if you raise less than $1 million.

ANSWER: In Amendment No.1 to Form SB-2, we have added a section on a net raise of $700,000.

28. State whether any of the proceeds will be used to compensate officers and directors. We note the reference to allocation of working capital to salaries. If so, please name the officer or director and state the amount so allocated.

ANSWER: In Amendment No.1 to Form SB-2, we have added information on the compensation to officers and directors.

29. Reconcile the disclosure regarding how long the maximum offering will sustain your business. You refer in this section to both 12 and 18 months.

ANSWER: In Amendment No.1 to Form SB-2, we have added language stating that the maximum offering of $4,400,000 will sustain FFB for 18 months. We also have language stating that a raise of $1,000,000 will sustain FFB for 12 months.

Management's Discussion and Analysis General

30. The disclosure in the last sentence of the first paragraph is repetitive. Revise as appropriate.

ANSWER: In Amendment No.1 to Form SB-2, we have deleted this sentence.

31. The disclosure in the second paragraph is confusing. For example, we do not understand that statement that you "believe that the effect implementation of our business plan will result in our position as a provider of wellness programs to the business..." Please revise.

ANSWER: In Amendment No.1 to Form SB-2, we have revised the disclosure in the second paragraph.

Results of Operations and Liquidity and Capital Resources ---------------------------------------------------------

32. Please explain the statement that you have conducted operations since 1998 when your business was not incorporated until 2001. Please include disclosure required by Item 101(a) of Regulation S-B r

Show Raw Text
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.txt
<TEXT>

May 4, 2005

Jay Ingram, Esq.
United States Securities and Exchange Commission
450 Fifth Street, N.W.
Washington, D.C. 20549

RE:   Fit For Business International, Inc. ("FFB")
      Registration Statement on Form SB-2
      Filed: March 7, 2005
      File No. 333-123176

Dear Mr. Ingram:

We have reviewed your April 6, 2005 letter and have the following responses:

General
-------

       1.     We note that your registration  statement  registers the resale of
              up to 2,870,000 shares of common stock by selling shareholders. We
              also note  that  there is  currently  no  market  for your  common
              shares.  Given this, please revise your prospectus cover page, the
              risk  factors  section,  and the plan of  distribution  section to
              provide that selling security holders will sell at a stated, fixed
              price until the  securities  are quoted on the OTC Bulletin  Board
              and,  thereafter,   the  selling  security  holders  may  sell  at
              prevailing market prices or privately  negotiated prices. See Item
              16 of Schedule A to the Securities Act of 1933.  Recalculate  your
              registration fee, if necessary, based upon this offering price.

ANSWER:  In Amendment No. 1 to Form SB-2, we have made the requested  changes on
the prospectus cover page and plan of distribution, added a risk factor and plan
of  distribution.  Based on our revisions,  there was no need to recalculate the
registration fee.

       2.     We note the registration of 2,000,000 shares of common stock to be
              issued "in  connection  with the  conversion of options  issued to
              Fort Street  Equity." You are reminded  that it is the position of
              the staff that the securities underlying securities that were sold
              privately  must  also  be  converted   privately  pursuant  to  an
              exemption   from   registration.   They   are  part  of  the  same
              transaction.  Only the resales of the underlying securities may be
              registered  by this  registration  statement  and the  exercise or
              conversion  transaction  between the selling  shareholders and the
              company remains  private,  subject to the limitations of available
              exemptions.  Please revise  disclosure  throughout  the prospectus
              accordingly.

ANSWER:  In Amendment No. 1 to Form SB-2, we have made the requested  changes to
indicate  that FFB is  registering  the  resale  of the  shares  underlying  the
conversion of options.

<PAGE>

       3.     Revise  your  disclosure  referencing  your  intent  to  have  the
              company's  securities  listed on the OTC Bulletin Board to clarify
              that there is no assurance that such securities will be listed for
              trading on the OTC Bulletin Board.

ANSWER:  In  Amendment  No. 1 to Form SB-2,  we have revised our  disclosure  to
clarify that there is no assurance that FFB's  securities  will be quoted on the
OTC Bulletin Board.

       4.     Please provide the  disclosure  required by Item 510 of Regulation
              S-B,  Disclosure of  Commission  Position on  Indemnification  for
              Securities Act Liabilities.

ANSWER: The original filed SB-2 registration statement contained the information
required by this question in Item 24 (Commission's  position on indemnification)
and Item 28 (B) (undertaking in the first sentence of Item 512(e)).

Prospectus Cover Page
---------------------

       5.     Please limit your disclosure on the cover page to that information
              required by Item 501 of  Regulation  S-B.  For  example,  consider
              removing  the  reference  to the state of  incorporation,  the par
              value of the common stock,  and the  information  contained in the
              third paragraph. Since the information in the third paragraph will
              be addressed later in the  prospectus,  you do not need to include
              this  disclosure  on the  cover  page.  Also,  please  remove  all
              parenthetically   defined  terms  such  as  "the   Company,"  "the
              Offering,"  and "the  Initial  Offering  Period." The use of these
              defined terms inhibits the readability of the cover page.

ANSWER:  In Amendment  No. 1 to Form SB-2,  we have made  revisions to limit our
disclosure on the cover page.

       6.     Please  limit the  outside  front cover of the  prospectus  to one
              page. Refer to Item 501(a) of Regulation S-B.

ANSWER:  In Amendment No. 1 to Form SB-2, we have limited the front cover of the
prospectus to one page.

       7.     Please disclose the type of offering by the company. For instance,
              is  this  a  self  underwritten  no  minimum,  minimum-maximum  or
              all-or-none?  Also,  please disclose whether there are any minimum
              purchase   requirements   and   whether   or  not  there  are  any
              arrangements  to place the funds in an  escrow,  trust or  similar
              account, as required by Item 501(a)(9)(iii) of Regulation S-B.

ANSWER:  In Amendment No. 1 to Form SB-2, we have included language stating that
the offering is a self  underwritten,  no minimum  offering and that there is no
requirement to place any proceeds in escrow.

       8.     Clarify what you mean when you disclose that the company's  shares
              "are not listed on any recognized exchange."

<PAGE>

ANSWER:  In Amendment No. 1 to Form SB-2, we have deleted the word  "recognized"
and added the word "stock."

       9.     Revise  your  cross-reference  to  the  risk  factors  section  by
              including a page number where the risk factors  section appears in
              the prospectus. See Item 501(a)(5) of Regulation S-B.

ANSWER:  In Amendment No. 1 to Form SB-2, we have added a cross  reference  page
number.

       10.    Please provide the disclosure  required by Item  501(a)(9)(iv)  of
              Regulation S-B.

ANSWER:  In  Amendment  No.  1 to Form  SB-2,  we  have  provided  the  required
disclosure.

       11.    We do not understand the following disclosure:  "This registration
              statement  will be amended  and  completed  from time to time,  as
              necessary." Supplementally advise.

ANSWER: In Amendment No. 1 to Form SB-2, this statement has been deleted.

Inside Front and Outside Back Cover Page
----------------------------------------

       12.    Please  provide  the  dealer  prospectus  delivery  obligation  as
              required by Item 502(b) of Regulation S-B.

ANSWER:  In Amendment No. 1 to Form SB-2, we have provided the dealer prospectus
delivery obligation.

Prospectus Summary
------------------

       13.    Please add summary financial data.

ANSWER:  In Amendment No. 1 to Form SB-2, we have added a summary financial data
table.

       14.    Please add  disclosure  addressing  the  company's  going  concern
              qualification.

ANSWER: In Amendment No. 1 to Form SB-2, we have added disclosure  regarding the
company's going concern qualification.

About Us
--------

       15.    Clarify your  disclosure  in this section  regarding the corporate
              history  of the  registrant.  For  example,  when  addressing  the
              acquisition of all of the issued and outstanding shares of Fit For
              Business (Australia) Pty Limited, consider disclosing that Mark A.
              Poulsen  and Mark  Poulsen  &  Associates  Pty.  Ltd  were,  as it

<PAGE>

              currently  appears,  100% owners of Fit For Business  (Australia).
              Also,  in the  second  paragraph,  explain  your  use of the  term
              "wholly  owned  subsidiary"  as it relates to the reverse  merger.
              Revise  similar  disclosure in the  "Business"  section.  Are your
              operations  conducted through your subsidiary?  If so, please make
              this explicit.

ANSWER: In Amendment No. 1 to Form SB-2, we have made the requested disclosures.

Securities Offered By Us
------------------------

       16.    Please  add  disclosure  addressing  the  nature of the  secondary
              offerings.

ANSWER: In Amendment No. 1 to Form SB-2, we have added the requested disclosure.

       17.    Please  explain  the  statement  on  page  8  that  "you  will  be
              purchasing  our  shares  from  us and  not  our  selling  security
              holders." This registration  statement  includes the resale of the
              selling security holders.

ANSWER: This statement has been deleted. This statement was included to disclose
that  purchasers of the 1,500,000  shares offered were receiving the shares from
us and not from the shares being offered by the selling security holders.

Risk Factors
------------

       18.    Please add an  introductory  paragraph  that states all "material"
              risks are disclosed in this section.

ANSWER: In Amendment No. 1 to Form SB-2, we have added such disclosure.

       19.    Revise   your  risk  factor   subheadings   to  ensure  that  your
              subheadings  clearly  reflect the  material  risk  enclosed in the
              narrative.  For example,  the  subheading for risk factor 4 merely
              states the fact your  business is subject to extensive  government
              regulation. Please revise your subheadings so that they adequately
              describe the specific  risk that results from the stated fact.  To
              assist  you in  this  regard,  we  refer  you to "  Plain  English
              Handbook-How to Create Clear SEC Disclosure  Documents," issued by
              the  Office  of  Investor  Education  and  Assistance,   which  is
              available on our website at www.sec.gov , and the updated  version
              of Staff Legal Bulletin No. 7, dated June 7, 1999.

ANSWER:  In  Amendment  No.1 to Form  SB-2,  we have  revised  the  risk  factor
headings.

       20.    In the first risk factor,  disclose the circumstances  under which
              the stated  risk could  materialize.  For  example,  describe  the
              circumstances   under  which  the  company  will  lose  these  key
              personnel. Also, explain why these persons are "essential" to your
              operations and growth. What are the roles and  responsibilities of
              these individuals?

ANSWER:  In Amendment  No.1 to Form SB-2,  we have revised the first risk factor
accordingly.

<PAGE>

       21.    Please  avoid  generic  conclusion  you reach in many of your risk
              factors that the risk could  negatively  impact or have an adverse
              effect on your  business or your  business  could suffer  negative
              consequences.   Instead,   replace  this  language  with  specific
              disclosure of how your business and operations would be affected.

ANSWER:  In Amendment  No.1 to Form SB-2,  we have revised  certain risk factors
accordingly.

       22.    Consider  combining the fourth and fifth risk factor, as they both
              focus on the governmental  regulations regarding your business and
              Herbalife.

ANSWER:  In Amendment  No.1 to Form SB-2,  we have combined the fourth and fifth
risk factor.

       23.    Please  remove  risk  factors  six and nine,  as they are  generic
              risks.

ANSWER:  In  Amendment  No.1 to Form SB-2,  we have removed risk factors six and
nine.

       24.    Please add risk factors  discussing  dilution to investors in this
              offering,  risks  associated  with  doing  business  in a  foreign
              country,  currency  fluctuations,  and the going concern raised by
              the independent auditors.

ANSWER:  In Amendment  No.1 to Form SB-2, we have added risk factors as follows:
dilution to investors in this offering,  risks associated with doing business in
a foreign country,  currency  fluctuations,  and the going concern raised by the
independent auditors.

Use of Proceeds
---------------

       25.    To the extent practicable, please provide more specific disclosure
              regarding  the  allocation  of  the  use  of  proceeds.  For  each
              enumerated use, add disclosure  discussing the items that comprise
              each use. We  specifically  refer you to the Multi Media  Training
              Programs;  Marketing,  Promotion  Literature  and  Brand  Campaign
              Costs; International Market Development. Currently, the disclosure
              is vague.  Also,  provide more  specificity  concerning the amount
              allocated to working capital.

ANSWER:  In  Amendment  No.1 to Form  SB-2,  we have added  specific  disclosure
regarding the allocation of the use of proceeds.

       26.    We note  your  statement  that  the  "[t]he  net  proceeds  may be
              reallocated  among the  categories  set forth  above or  otherwise
              depending  upon the  state of our  business  operations  and other
              factors,  many of which are beyond our  control."  Be advised that
              you may change the use of proceeds  provided such  reservation  is
              due to certain  contingencies that are specifically  discussed and
              the alternatives to such use are indicated. Refer to Instruction 7
              to Item 504 of  Regulation  S-K for  guidance.  Please revise your
              disclosure accordingly.

<PAGE>

ANSWER:  In Amendment No.1 to Form SB-2, we have deleted this sentence.

       27.    Please  discuss the  allocation of proceeds if you raise less than
              $1 million.

ANSWER:  In Amendment  No.1 to Form SB-2, we have added a section on a net raise
of $700,000.

       28.    State  whether  any of the  proceeds  will be  used to  compensate
              officers and  directors.  We note the  reference to  allocation of
              working  capital to  salaries.  If so,  please name the officer or
              director and state the amount so allocated.

ANSWER:  In  Amendment  No.1 to Form  SB-2,  we have  added  information  on the
compensation to officers and directors.

       29.    Reconcile the disclosure  regarding how long the maximum  offering
              will sustain your  business.  You refer in this section to both 12
              and 18 months.

ANSWER:  In Amendment No.1 to Form SB-2, we have added language stating that the
maximum  offering of  $4,400,000  will  sustain FFB for 18 months.  We also have
language stating that a raise of $1,000,000 will sustain FFB for 12 months.

Management's Discussion and Analysis
General

       30.    The  disclosure  in the last  sentence of the first  paragraph  is
              repetitive. Revise as appropriate.

ANSWER:  In Amendment No.1 to Form SB-2, we have deleted this sentence.

       31.    The disclosure in the second paragraph is confusing.  For example,
              we do not  understand  that  statement  that you "believe that the
              effect  implementation  of our  business  plan will  result in our
              position as a provider of  wellness  programs to the  business..."
              Please revise.

ANSWER:  In Amendment  No.1 to Form SB-2, we have revised the  disclosure in the
second paragraph.

Results of Operations and Liquidity and Capital Resources
---------------------------------------------------------

       32.    Please explain the statement  that you have  conducted  operations
              since 1998 when your  business  was not  incorporated  until 2001.
              Please  include  disclosure  required by Item 101(a) of Regulation
              S-B r